Evidence map›Paper›PMID 36039874›Full record

ArticleEnvironmental toxicology2022

Xiaotansanjiefang inhibits the viability of colorectal cancer cells via Jagged 1/Notch 3/Snail signaling pathway.

Min Ye, Jiaqi Du, Xiaowei Wang, Lijuan Xiu, Xuan Liu, Yufang Gu, Bei Pei, Dazhi Sun, Xiaoqiang Yue

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Environmental toxicology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Min YeDepartment of Traditional Chinese Medicine, Changzheng Hospital, Second Military Medical University, Shanghai, China.ORCID https://orcid.org/0000-0002-7077-113X
Jiaqi DuDepartment of Bai's Proctology, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Xiaowei WangDepartment of Traditional Chinese Medicine, Changzheng Hospital, Second Military Medical University, Shanghai, China.
Lijuan XiuDepartment of Traditional Chinese Medicine, Changzheng Hospital, Second Military Medical University, Shanghai, China.
Xuan LiuDepartment of Traditional Chinese Medicine, Changzheng Hospital, Second Military Medical University, Shanghai, China.
Yufang GuDepartment of Traditional Chinese Medicine, Changzheng Hospital, Second Military Medical University, Shanghai, China.
Bei PeiDepartment of Traditional Chinese Medicine, Changzheng Hospital, Second Military Medical University, Shanghai, China.
Dazhi SunDepartment of Traditional Chinese Medicine, Changzheng Hospital, Second Military Medical University, Shanghai, China.
Xiaoqiang YueDepartment of Traditional Chinese Medicine, Changzheng Hospital, Second Military Medical University, Shanghai, China.ORCID https://orcid.org/0000-0002-4777-8624
Second Military Medical University · CNShanghai University of Traditional Chinese Medicine · CN

Funding

National Natural Science Foundation of China 81703967
6 · The paper itself

Abstract

The purpose of this study is to explore the anti-colorectal cancer of Xiaotansanjiefang, a famous traditional Chinese medicine, and its potential anti-cancer mechanism. In this study, the HCT116 cell spheres were prepared as in vitro study model. We found the Xiaotansanjiefang medication was able to inhibit the proliferation of HCT116 cell spheres in a dose-dependent manner, especially in 3 and 6 mg/ml Xiaotansanjiefang medication treated groups. We also found the high concentration of Xiaotansanjiefang medication could suppress the migration and promote the apoptosis of HCT116 cell spheres. Moreover, we found the expression of Jagged 1, Notch 3, Snail, and Hes 1 were decreased in HCT116 cell spheres treated with Xiaotansanjiefang medication. Furthermore, the proliferation and apoptosis behaviors of HCT116 cell spheres treated with Xiaotansanjiefang medication were reversed with the addition of Jagged 1 Fc chimera protein. The expression of Jagged 1, Notch 3, Snail, and Hes 1 were also increased again in HCT116 cells treated with Xiaotansanjiefang medication plus with Jagged 1 Fc chimera protein. The presented study may provide a promising strategy to treat and prevent colorectal cancer.

Indexed as

Intercellular Signaling Peptides and ProteinsNeoplasmsCalcium-Binding ProteinsCell ProliferationJagged-1 ProteinMembrane ProteinsSerrate-Jagged ProteinsSignal TransductionCalcium-Binding ProteinsIntercellular Signaling Peptides and ProteinsJagged-1 ProteinMembrane ProteinsSerrate-Jagged Proteinsapoptosiscolorectal cancerJagged 1/Notch signalingproliferationtraditional Chinese medicine

Identifiers

PMID36039874
OpenAlexW4293577221

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.